Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab

Journal

Therapeutic Advances in Medical Oncology

Journal Volume

13

Date Issued

2021

Author(s)

Rimassa L.

Sun H.-C.

Vogel A.

Kaseb A.O.

DOI

10.1177/17588359211031141

URI

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85111475007&doi=10.1177%2f17588359211031141&partnerID=40&md5=715daa24c061bb51ee109c493b32fd33

https://scholars.lib.ntu.edu.tw/handle/123456789/617102

SDGs

[SDGs]SDG3

Publisher

SAGE Publications Inc.

Type

review